Worst performers so far have been Healthcare and personal products. High valuations do tend to have that impact… then again the healthcare issue seems to be 1) no new diseases that have made people rush to the hospitals 2) drop in ME patients 3) SSO impact. A little hurray must be said for the automotive sector recovering price wise, actually companies performance isn’t anything to write home about yet.